DiscGenics, Inc., a privately held, late-stage clinical, biopharmaceutical company developing allogeneic, cell-based, regenerative therapies for musculoskeletal degeneration, today announced that the ...

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against GSK ...

British drugs firm GSK has been accused of burying a report said to prove a link between its medication Zantac and cancer, a new lawsuit has claimed. A pension fund has filed a class action ...

Follow our latest tariffs coverage in our live blog; Donald Trump has paused his tariff onslaught for 90 days in a major ...

It was followed by rival GSK, which tumbled 5.7 per cent, or 76.5p, to 1264p. The slump in drugmakers’ stocks came after the US president said overnight that the US would soon introduce a ...

New York, New York--(Newsfile Corp. - March 22, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Receipts ("ADRs") of GSK plc (NYSE: GSK) ...

GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has ...

Astrazeneca plunged seven per cent and GSK 5.7 per cent ... According to White House documents, medicine had previously been exempt from tariffs. The President has not specified when or how ...

Measles outbreak claims second life in Texas as new Health Secretary Robert F. Kennedy, Jr. changes his anti-vaccine stance.